Literature DB >> 7458435

Gold in erythrocytes, whole blood, and plasma during long-term chrysotherapy.

S M Pedersen, P M Graabaek.   

Abstract

The concentrations of gold in erythrocytes, whole blood, cell-rich plasma, and cell-free plasma were investigated in 17 patients with rheumatoid arthritis undergoing long-term chrysotherapy. Gold estimations were performed with a graphite tube atomic absorption spectrophotometer. Significant quantities of gold were found in isolated erythrocytes of 12 patients. There was no correlation between erythrocyte gold and therapeutic response, plasma gold, and gold in whole blood. Nor did gold in whole blood or plasma show any correlation with therapeutic responses and toxic reaction. However, all patients (3) with toxic reactions had a significantly higher gold concentration in the erythrocytes than the patients without toxic reactions. This result indicates that erythrocyte gold estimations could provide a useful warning of impeding toxic reactions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7458435      PMCID: PMC1000624          DOI: 10.1136/ard.39.6.576

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  Chrysotherapy: pharmacological and clinical correlates.

Authors:  A Lorber; T M Simon; J Leeb; P E Carroll
Journal:  J Rheumatol       Date:  1975-12       Impact factor: 4.666

2.  Distribution of gold in blood during chrysotherapy.

Authors:  P E Francois; I J Goldberg; K Lawton; D T Al-Ani; J H Redding
Journal:  Ann Clin Biochem       Date:  1978-11       Impact factor: 2.057

3.  Blood and urine gold levels during chrysotherapy for rheumatoid arthritis.

Authors:  R Billings; R Grahame; V Marks; P J Wood; A Taylor
Journal:  Rheumatol Rehabil       Date:  1975-02

4.  METABOLISM, TOXICITY AND MANNER OF ACTION OF GOLD COMPOUNDS USED IN THE TREATMENT OF ARTHRITIS. I. HUMAN PLASMA AND SYNOVIAL FLUID CONCENTRATION AND URINARY EXCRETION OF GOLD DURING AND FOLLOWING TREATMENT WITH GOLD SODIUM THIOMALATE, GOLD SODIUM THIOSULFATE, AND COLLOIDAL GOLD SULFIDE.

Authors:  R H Freyberg; W D Block; S Levey
Journal:  J Clin Invest       Date:  1941-07       Impact factor: 14.808

5.  Studies with radioactive gold.

Authors:  J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1961-12       Impact factor: 19.103

6.  Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate.

Authors:  J D Jessop; R G Johns
Journal:  Ann Rheum Dis       Date:  1973-05       Impact factor: 19.103

7.  Pharmacodynamics of 197Au and 195Au labeled aurothiomalate in blood. Correlation with course of rheumatoid arthritis, gold toxicity and gold excretion.

Authors:  N L Gottlieb; P M Smith; E M Smith
Journal:  Arthritis Rheum       Date:  1974 Mar-Apr

8.  Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis.

Authors:  A Lorber; C J Atkins; C C Chang; Y B Lee; J Starrs; R A Bovy
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103

9.  Gold distribution in whole blood during chrysotherapy.

Authors:  P M Smith; E M Smith; N L Gottlieb
Journal:  J Lab Clin Med       Date:  1973-12

10.  A unified method for the determination of gold in biological fluids by flameless atomic absorption spectroscopy.

Authors:  S M Pedersen; P M Graabaek
Journal:  Scand J Clin Lab Invest       Date:  1977-02       Impact factor: 1.713

View more
  6 in total

1.  Gold nanoparticles: a revival in precious metal administration to patients.

Authors:  A S Thakor; J Jokerst; C Zavaleta; T F Massoud; S S Gambhir
Journal:  Nano Lett       Date:  2011-09-07       Impact factor: 11.189

Review 2.  Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.

Authors:  M Chaffman; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

3.  Gold levels produced by treatment with auranofin and sodium aurothiomalate.

Authors:  D Lewis; H A Capell; C J McNeil; M S Iqbal; D H Brown; W E Smith
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

4.  Effect of two gold compounds on lysosomes.

Authors:  P M Graabaek; S M Pedersen
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

5.  Neutrophil migration in response to chemotactic factors: effects of generation conditions and chemotherapeutic agents.

Authors:  R A Turner; J A Johnson; J D Mountz; W J Treadway
Journal:  Inflammation       Date:  1983-03       Impact factor: 4.092

6.  ICP-MS trace element analysis in serum and whole blood.

Authors:  Nico Laur; Ralf Kinscherf; Karolina Pomytkin; Lars Kaiser; Otto Knes; Hans-Peter Deigner
Journal:  PLoS One       Date:  2020-05-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.